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Abstract
Background: During the 2009-2010 A(H1N1) pandemic, many people did not seek care quickly enough, failed to
take a full course of antivirals despite being authorised to receive them, and were not vaccinated. Understanding
facilitators and barriers to the uptake of vaccination and antiviral medicines will help inform campaigns in future
pandemic influenza outbreaks. Increasing uptake of vaccines and antiviral medicines may need to address a range
of drivers of behaviour. The aim was to identify facilitators of and barriers to being vaccinated and taking antiviral
medicines in uncertain and severe pandemic influenza scenarios using a theoretical model of behaviour change,
COM-B.
Methods: Focus groups and interviews with 71 members of the public in England who varied in their at-risk status.
Participants responded to uncertain and severe scenarios, and to messages giving advice on vaccination and antiviral
medicines. Data were thematically analysed using the theoretical framework provided by the COM-B model.
Results: Influences on uptake of vaccines and antiviral medicines - capabilities, motivations and opportunities - are
part of an inter-related behavioural system and different components influenced each other. An identity of being
healthy and immune from infection was invoked to explain feelings of invulnerability and hence a reduced need
to be vaccinated, especially during an uncertain scenario. The identity of being a ‘healthy person’ also included
beliefs about avoiding medicine and allowing the body to fight disease ‘naturally’. This was given as a reason for
using alternative precautionary behaviours to vaccination. This identity could be held by those not at-risk and by
those who were clinically at-risk.
Conclusions: Promoters and barriers to being vaccinated and taking antiviral medicines are multi-dimensional
and communications to promote uptake are likely to be most effective if they address several components of
behaviour. The benefit of using the COM-B model is that it is at the core of an approach that can identify effective
strategies for behaviour change and communications for the future. Identity beliefs were salient for decisions about
vaccination. Communications should confront identity beliefs about being a ‘healthy person’ who is immune from
infection by addressing how vaccination can boost wellbeing and immunity.
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The 2009 A/(H1N1) influenza pandemic was less mark-
edly severe than previous strains such as the H3N2 virus
in 1968 [1]. The groups that were most at-risk from
infection were those aged below 19 years [2], pregnant
women and individuals with underlying illnesses such
as diabetes, asthma, respiratory diseases, immune sup-
pression and renal disease [3]. One dose of pandemic
vaccine conferred good protection against the infection
in approximately 70% of cases [4]. However, despite the
effectiveness of the vaccine, the public demand for vac-
cination was low and many people were not vaccinated.
For example, in the UK uptake of vaccination among
clinically at-risk groups was 37.6% [5]. For those who
contracted pandemic influenza, antiviral medicines were
recommended as a treatment, and the provision of anti-
viral medicines (also as a preventive measure) was a major
component of emergency plans in many countries [6].
Data from the UK National Pandemic Flu Service (NPFS)
indicated that of the 1.8 m courses of antiviral medicines
that were authorised, only 1.16 million were collected and
many patients failed to complete a full course [7]. This
suggests that there is a need to develop effective commu-
nications to improve uptake and to consider how best to
advise the public on the nature of the disease, why they
should seek prevention (vaccination) or treatment (antiviral
medication), who should seek it and when.
Evidence shows that the factors that have been found to
promote uptake of vaccination included being vaccinated
for seasonal flu [8-10], perceiving that the outbreak was se-
vere and resulting in high morbidity and mortality [11,12],
high levels of worry and anxiety [13], being in a priority
group [14] and believing that the vaccine was effective and
safe [14,15]. In addition, social influences were important;
for example knowing someone who had the disease and
knowing that others had a favourable view of the vaccine
[11] as well as trust in the source of information
[11,15-17]. Factors that have been found to act as barriers
to uptake of pandemic influenza vaccination were: believ-
ing that the outbreak was not serious [16,17], and not iden-
tifying oneself as being at-risk [17]. Fears about the safety
and side effects of the vaccine were also a barrier to H1N1
vaccine uptake [8,14,18-20]. It appeared that the public
preferred to take the risk of harm posed by the disease over
any harm that might be caused by being vaccinated
[21,22]. The scant research in the UK and elsewhere about
the public’s response to antiviral medicines in the last pan-
demic suggests that the public knew relatively little about
antiviral medicines and had limited experience of their use
[23]. Frequent travellers had more positive perceptions of
antiviral medication as a result of prior usage [24,25] and
research with pregnant women found a tension between
women’s desire to protect the foetus from harm and worry
about the safety of taking medicines when pregnant [26].
Research conducted with the public in advance of an
outbreak can inform the type of messages that are likely
to be effective in promoting acceptance of these recom-
mended behaviours [27,28]. Such past research has
investigated hypothetical scenarios of varying degrees of
severity and advice on a variety of precautionary behav-
iours including hand-washing, covering the mouth, vac-
cination and seeking medical attention [29-32]. Results
showed that the public was largely unfamiliar with the
term ‘pandemic’ and tended to believe that pandemic
influenza was similar to seasonal influenza [29,31].
Most people do not know whether the symptoms of
pandemic flu are different from pandemic influenza and
are unsure how to recognise the signs [29,32,33].
This body of research suggests that, in a future pan-
demic, the public would benefit from more knowledge
about the health threat and about who will be at-risk
from infection, how the infection spreads, how to
self-diagnose, short and long term consequences of the
illness if precautionary measures are not taken, and the
potential side effects of vaccination and antiviral drug
treatments [30-32,34,35], including safety and efficacy
tests for a new vaccine that would be rapidly deployed
[30]. In some instances, trust was found to be an
important component in acceptance and compliance
with recommended behaviours; however, trust in public
officials has been found to be weak compared with trust
in medical professionals [31,34,36-38]. Although the
research described above has identified a range of factors
promoting pandemic vaccination, there is less about those
factors influencing uptake of antiviral medicines.
While research has often focused on the public’s
response to advice during severe or moderate pandemic
outbreaks little is known about how the public would
respond to advice in an explicitly uncertain situation
where the risk is less clear cut. For example, Teasdale &
Yardley [32] studied the public’s response to advice in
scenarios where the consequences were described as
moderate or severe; Elledge and collegues [31] investi-
gated mild and severe scenarios for avian flu and
McGlone et al studied [39] responses to a severe sce-
nario. Understanding how the public responds when the
progress and impact of a pandemic is uncertain will be
important because it is during the emergent, uncertain
stages of a pandemic that the public will be asked to
consider the potential risk of contracting pandemic
influenza and to take precautionary measures to reduce
the likelihood of personal infection and spread.
The majority of studies that have investigated how the
public respond to precautionary advice has rarely been
informed by a theoretical understanding of behaviour
change. Using a theoretical framework helps to integrate
empirical findings and elucidate processes of change and
mechanisms of action of effective communication and
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purpose is the COM-B model summarising factors
necessary for behaviour to change across behavioural
domains [40] (Figure 1). The initials stand for ‘capabil-
ity’, ‘opportunity’, ‘motivation’ and ‘behaviour’, and the
model recognises that behaviour is part of an interacting
system involving all these components. Changing behav-
iour will involve changing one or more of them in such
a way as to put the behavioural system into a new con-
figuration and minimise the risk of it reverting. Because
of the interacting nature of these components, one may
increase, for example, motivation by increasing capability
(e.g. knowledge and skills) and opportunity (e.g. access to
resources and social influence).
We adopted the COM-B model in our approach to the
uptake of pandemic flu vaccination and antiviral medi-
cines because changing the incidence of any behaviour
in a group or population is likely to involve changing
more than one driver of behaviour.
By specifying the factors that need to change for a
behaviour to occur, the model can identify the kinds of
interventions that are likely to be effective. The model
postulates that for any behaviour to occur a person must
have the psychological and physical capability to perform
the behaviour; the physical and social opportunity to
engage in it, and must be motivated to do so at the
relevant moment compared with some other behaviour.
Psychological and physical capability refers to the range
of capacities such as knowledge, physical and mental
skills and facilities such as strength and stamina. Oppor-
tunity can be physical and social and refers to environ-
mental factors that permit the behaviour including access,
availability, time and financial resources and social factors
such as the cultural milieu we operate in. Motivation
reflects the brain processes that direct behaviour which
may be reflective (evaluations and plans) or automatic
(emotions and impulses arising from associated learning).
COM-B has been elaborated into 14 theoretical domains,
the Theoretical Domains Framework (TDF) [41].
The study aimed to systematically identify facilitators
of and barriers to being vaccinated and taking antiviral
medicines in uncertain and severe pandemic influenza
scenarios using the COM-B framework. An uncertain
scenario was used in addition to a severe scenario
because in the early stages of a pandemic there is often
uncertainty about how the situation will unfold, how
rapidly the infection will spread, or what impact this
could have on the population. Hence it is important to
understand how people respond to precautionary advice
in these conditions of uncertainty, how they make sense
of the risk, and what types of precautionary measures
they express preference for.
Method
Design and recruitment
Semi-structured focus groups and interviews were con-
ducted with a diverse sample of the general public. To
ensure that participants were from a range of social and
ethnic backgrounds we recruited from a variety of orga-
nizations in London and Southampton including chil-
dren’s centres, AgeUK lunch clubs, community centres,
students from a university, voluntary organisations and
support groups for those with underlying conditions
such as diabetes, COPD (Chronic Obstructive Pulmon-
ary Disease) and PSC (Primary Sclerosing Cholingitis).
Advertisements were placed in these centres explaining
the purpose of the study, who was eligible, how to par-
ticipate and offering a small monetary compensation for
Figure 1 Schematic of the components and relationships in the COM-B model.
Rubinstein et al. BMC Public Health  (2015) 15:190  Page 3 of 13participation. The managers of the centres where inter-
views were held advertised the study and made rooms
available for the focus groups to take place.
Ethical approval for the study was granted by University
College London (Reference: 5081/001) and the University
of Southampton (Reference: 7387) ethics committees.
Sample
Sampling was purposeful and individuals who varied in
their risk status were recruited. Of the 71 participants,
23 were men and 48 were women; Details of the demo-
graphic profile are shown in Table 1. Thirty-five were
from designated at-risk groups of whom 10 had an
underlying condition, and six were pregnant. Of the 36
participants not designated as being at-risk, nine were
specifically recruited because they were mothers with
young children. Thirty-eight of the participants were
vaccinated for seasonal influenza regularly (of whom 20
were from clinical at-risk groups) and two had been
vaccinated for seasonal influenza for the first time this
year. Eighteen people who did not consider themselves
to be at risk had been vaccinated at least once before for
seasonal influenza. Reasons for being vaccinated among
those who were designated as not being at high risk
included recommendation by a GP, and being offered
the vaccine at work. 12 participants had received mono-
valent H1N1 vaccine and three had antiviral medicines
during the 2009-2010 pandemic.
It should be noted that groups were not always mutu-
ally exclusive. For example, some individuals who had
been recruited as ‘elderly’ (over 65 years of age) also
reported that they had other underlying conditions that
would put them in another at-risk category.
Materials
Two scenarios were developed: an uncertain and a severe
scenario. The severe scenario was based on that used by
Teasdale and Yardley (2011) which described a severe level
of risk, severe health consequences and the national im-
pact of the pandemic. The uncertain scenario was devel-
oped to reflect the early conditions that occurred during
the 2009/10 pandemic. This described an uncertain situ-
ation, uncertain health consequences and uncertain public
impact of the pandemic (see Table 2).
Short messages promoting the uptake of vaccinations
and antiviral medicines for pandemic influenza were
developed to reflect evidence from prior research that
identified barriers to uptake but also to reflect the key
drivers of behaviour as defined in the COM-B frame-
work. These were presented as advice from official
sources (see Table 3).
Procedure
Data collection took place in London and Southampton
from November 2013 to March 2014. Nine focus groups,
three paired interviews and six individual interviews
were conducted by the first two authors at the centres
from which participants were recruited. Written in-
formed consent was obtained from all participants who
received a small monetary compensation for their in-
volvement. Interviews lasted between 20 and 65 minutes
and were audio recorded with the participants’ consent.
An interview schedule structured into two sections
was used to guide the discussion. The first section was
to establish what participants knew about pandemic
influenza, vaccinations, and antiviral medicines for pan-
demic influenza, and personal experiences of pandemic
influenza. The second section focused on responses to
two scenarios and advice concerning vaccinations and
antiviral medicines. Participants were asked to imagine
that they were in a given situation and to consider what
they would think, feel and do if this were to occur. The
Uncertain scenario (Table 2) was always shown first,
followed by the advice about antiviral medicines (Table 3).
The Severe scenario (Table 2) was shown second followed
b yt h ea d v i c eo nv a c c i n a t i o n s( T a b l e3 ) ,a n dt h e na n t i v i r a l
medicines. All participants were debriefed in full at the
end of the interview and reassured that these were
fictional scenarios.
Table 1 Profile characteristics of participants
Gender Type of group
Male 23 Mothers/young children 9
Female 48 Elderly - aged 65 years and over 19
Underlying illness* 10
Pregnant 6
General public 27
Location Been vaccinated for seasonal flu
London 47 Yes 40
Southampton 24 No 31
Age Perceived risk of catching influenza
16-35 years 21 Not at risk 35
36-64 years 20 At risk 17
65 years and over 30 Not stated 19
Ethnicity H1N1 vaccine
White/White British 42 Yes 12
Black/Black African 22 No 56
Other 7 NA 3
Education Antiviral for H1N1
Secondary school 7 Yes 3
College 7 No 65
University educated 36 NA 3
Not stated 21
*i.e., diabetic, asthma, COPD.
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Audio recordings were transcribed verbatim and NVivo
10 was used to code and to maintain a trail of memo
and theme development. Analysis was iterative and each
transcript was read and re-read numerous times by the
first two authors independently. Transcripts were coded
line by line and analysed comparatively to identify simi-
larities and differences [42]. A data audit was conducted
by the first two authors to clarify meanings, remove
duplicated codes and identify data that did not match
the coding scheme [43].
Inductive analysis was used to identify responses to
the uncertain and severe scenarios. Deductive analysis
was used to identify facilitators and barriers to following
recommended advice to be vaccinated and take antiviral
medicines. In addition, code names were assigned to the
six COM-B components: physical and psychological
capabilities; automatic and reflective motivations, and
social and physical opportunities (see Additional files 1
and 2 – code frames). For the purposes of analysis, the
Theoretical Domains Framework [41] was used. This is
a variant of the COM-B which subdivides the themes
into 14 detailed components that map directly onto
COM-B. These are: ‘knowledge’; ‘skills’; ‘memory, atten-
tion and decision processes’; ‘behavioural regulation’;
‘social/professional role and identity’; ‘beliefs about cap-
abilities’; ‘optimism’; ‘beliefs about consequences’; ‘inten-
tions’; ‘goals’; ‘reinforcement ‘emotion’; ‘environmental
context and resources’;a n d‘social influences’
a.
The facilitators and barriers to being vaccinated and take
antiviral medicines were reviewed separately. Responses to
accepting advice were also investigated according to two
broad categories – those designated as being in a priority
group (35 people – men and women over 65 years, preg-
nant, underlying illnesses) and those not designated as
being in a priority group (36 people – men and women
under 65 years, mothers with young children).
Results
Responses to the uncertain and severe scenarios differed:
in the uncertain scenario participants were hesitant and
ambivalent about following advice because the risk was
unclear whereas in the severe scenario the need to act
seemed more obvious and almost all claimed they would
comply with the official advice.
The focus of this paper is on facilitators and barriers
to uptake of pandemic influenza vaccination, because
participants knew relatively little about antiviral medi-
cines and were less able to discuss them. Responses to
advice about antiviral medicine were more limited, as
the participants were largely unfamiliar with these medi-
cines, but were broadly similar to responses to advice
about being vaccinated; any differences are highlighted
after the responses in common are presented.
Responses to the scenarios: procrastination vs. call to
action
The most common response to the uncertain scenario
was to ‘wait and see’ or ‘do nothing yet’. There were two
reasons given for this: the situation was likened to the
swine flu outbreak, which was not considered to be ser-
ious, and it was thought to be distant - both emotionally
and physically - and hence, less worrying:
It hasn’t got into the country at the moment, so um
I’m not sure if there are people that have the
pandemic flu. (Pregnant woman
b)
Personal risk was perceived to be low, even amongst
those in a designated priority group. Although there was
Table 2 Uncertain and Severe Scenarios of Pandemic Influenza used in the research
Uncertain Scenario Severe scenario
The [pandemic] flu virus has not yet reached the area where you live but
it is now spreading to the UK. In other countries hundreds of people are
infected - some people do not have any symptoms but 15 have died.
Flu virus has spread to where you live, 1 in 2 of those coming into
close contact with an infected person catch flu.
Scientists do no yet know how badly the flu virus will affect people in
the UK - doctors are trying to learn about the virus as fast as they
can, but do not know if it will be mild or serious.
Most people who catch flu feel very ill for around a week. Almost 1
in every 10 people who catch flu need hospital care, and 1 in every 50
healthy people who catch flu die.
When the virus reaches the UK, we don’t know whether life will carry
on much as usual or whether there will be serious problems with services
such as the NHS, schools or vital supplies.
Life cannot continue as usual. Most schools close, there is very high
sickness absence at work and so there are problems with essential supplies,
and health care services are not coping and have to be prioritised for the
most seriously ill.
Table 3 Advice to take antiviral medicines and to be vaccinated used in the research
Antiviral medicines Vaccinations
PEOPLE WITH PANDEMIC FLU are advised to take antiviral medicines to
reduce their symptoms, and the length of time they are ill.
You are advised by your GP to get vaccinated at once to protect you
and your family from getting pandemic flu.
PEOPLE IN A PRIORITY GROUP will be provided with antiviral medicines
to prevent them from catching flu.
Vaccines for pandemic flu have been through the same careful tests
as vaccines for seasonal flu and are safe to use
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enced as disconcerting, the majority did not see the need
for vaccination or antiviral medicines. Rather, participants
suggested that they would do more of the behaviours they
already practiced such as following good hand and respira-
tory hygiene and taking more Vitamin C:
You’d step up your vitamin C etc. and your cod liver
oil. (Male, over 65 years)
I would be watching more people touching- for me per-
sonally, washing my hands er you know being aware if
someone sneezes I’d probably ask them to cover their
face. (Mother with young children)
In this situation, it was thought to be important to
‘keep an eye on the media’ to find out what general
advice was being given.
In contrast, the most common response to the severe
scenario was to take action.
32 million people in the UK with flu, yeah. Okay. I’m
off to the doctor. (Male, not at-risk)
You’d probably be ringing up your GP and going ‘In e e d
to look after my daughter - I don’t want to get it. Can
you put me in a priority group? (Female, not at-risk)
The ‘call to action’ occurred because this situation was
thought to be serious. ‘Serious’ was often interpreted in
terms of the disease being emotionally and physically
close rather than in terms of the absolute number of
people who were ill, hospitalised or had died.
If it is your neighbour - it is really – being really ill
with flu, if they got it and their baby got it it’sn e a rt o
you and you know people and I would feel influenced I
think. Well I’ve got a baby at home and my elderly
mum lives next door I should get it because I don’t
want to put them at-risk by me getting or vice versa
but if it is on the news and they are telling you in
China – you know whatever I am thinking ‘whatever,
am I at-risk? Is my family at-risk? It’s on the TV. I don’t
know –am I going to get this? (Female, not at-risk)
In severe scenarios, there was a high level of anxiety and
an awareness of personal susceptibility. As one woman
with young children commented ‘this is normal people
and they are dying’. The need to take novel precautionary
measures, of any kind, was less likely to be disputed:
I think people follow any advice [in this scenario] that
is given from an authority figure anyway, even if it
was poison…(Female, not at–risk)
Barriers and facilitators to vaccination uptake
Five of the six components in the COM-B model
accounted for participants’ responses (Table 4).
Capability
Knowledge
The majority of participants knew little about pandemic
influenza and many were unsure of the meaning of the
word ‘pandemic’. Overall, few people linked ‘pandemic
influenza’ to the A/H1N1 pandemic influenza outbreak
of 2009-2010. They tried to make sense of it by likening
it to other more familiar phrases such as ‘epidemic’,
inferring that it was probably a more widespread and
more serious form of influenza:
I just thought pandemic flu was all kinds of flu, I
didn’t…oh well I actually thought maybe pandemic
sounds like a flu that is outbreaking and very
dangerous and they want to keep it under control.
(Pregnant woman)
Only two people in the study spontaneously referred
to the fact that pandemic influenza is a novel strain of
virus. When this information was presented, people
found the notion of it being a novel strain helpful in
explaining the threat it posed beyond seasonal influenza:
It’s just the word they use when it is worldwide and it
is spreading from chickens in China or something, but
other than that I didn’t know what it meant, that it
was new, why don’t they just say new? I mean they want
new, it’s the new one for which there isn’t any vaccine
yet; that should be said. (Female, over 65 years)
In the absence of this new information, some thought
that pandemic influenza could be like seasonal influenza.
What are the symptoms? Are there different symptoms
from swine flu and ordinary flu? What would you look
out for? How would you know you had one from the
other? They could be the same. (Male, not at-risk)
Memory
Some participants spontaneously linked the word ‘pan-
demic’ to bird flu or swine flu but many did not. Recall
of the swine flu pandemic was low, partly because only
four participants in our sample had contracted it, and
partly because few knew anyone who had. A prevalent
comment was that media had exaggerated the risk of
swine flu:
It’s almost like you get kind of a mixed picture of what
it actually is, and then, it will be reported in a way
that people will think it’s…that they’re not going to be
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but then, the next day, it will be like, oh, actually,
there’s only one person in Yorkshire that’s got it…
(Female, not at-risk)
Motivations
Automatic motivations
In the uncertain scenario, the participants expressed lit-
tle concern about the pandemic outbreak. Most partici-
pants were not worried and so many could not see a
need to be vaccinated or take antiviral medicine:
…there’s nothing to do yet. I feel like this is worrying
about nothing (Male, not at-risk)
…it’s a good first step, I guess, you know, to try and get
the word out there that this could potentially be a
problem, but this wouldn’t be the deciding factor [to
be vaccinated]. (Pregnant female)
Having been offered the seasonal influenza vaccine
previously was put forward as a reason for considering
pandemic influenza vaccination – ‘it would never stop
me because I have been having them [seasonal flu jab]
for years and years’ (Female, underlying illness).
Reflective motivations
In the uncertain scenario, participants tended to make a
‘risk assessment’ (e.g. male, not at-risk) and ‘weigh up the
Table 4 Factors that can influence uptake of vaccine for pandemic influenza identified in the study using COM-B
CAPABILITY MOTIVATION OPPORTUNITY
The capacity to engage in the behaviour Brain processes that energise and direct
behaviour
Factors lying outside the individual that
act as barriers or promoters of behaviour
Psychological Automatic Physical
Capacity to engage in necessary thought
processes
Emotions and impulses Physical opportunity in the environment
Knowledge of the disease Emotion: Fear Access
￿ Pandemic influenza is a novel strain ￿ Expressed not just numerically but in terms
of physical and emotional proximity
￿ to treatments
￿ Awareness of morbidity, mortality and
transmission rates
￿ to professional advice
Memory Habitual behaviour Able to book to see GP
￿ Media exaggeration of last pandemic ￿ Being vaccinated for seasonal influenza and
taking medicines in general
Avoiding ‘hubs of infection’
Physical Reflective Social
Capacity to engage in necessary
physical processes
Evaluation and plans Cultural milieu that affects what we think about
things
￿ Not salient/not mentioned Beliefs about consequences Social influences
￿ Pandemic influenza is not more serious than
seasonal influenza
￿ Respected others are being vaccinated
￿ The vaccine has not been adequately tested
and may be unsafe or ineffective
￿ Believing that it is unacceptable to put others
at risk
Omission bias Trust
￿ Believing that the risks of being vaccinated outweigh
the risk of being ill with pandemic influenza
￿ Recommendation from trusted health
professional
￿ Respected others recommend
Identity (health) Group identity
￿ Believing that a healthy lifestyle confers immunity ￿ Being part of an at-risk support group
Optimistic bias
￿ Tending to the view that they will not be infected or
will make an easy recovery from pandemic influenza
Social role
￿ Responsibility for other family members, including
unborn
Anticipated regret
￿ Concern that the outbreak could be more serious
than expected and have not been vaccinated
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I going to lose my life or be significantly impacted by it’
(e.g. female, underlying condition). Participants delib-
erated about the consequences of being ill with influ-
enza as opposed to the consequences of being ill with
side-effects from the vaccine. In doing so, they drew
on their current status as a healthy person who would
not need to be vaccinated; on their role in society as
a responsible person who should be vaccinated to
prevent family members (especially children) from
becoming ill; and on feelings of anticipated regret if
the virus became worse and they had failed to be
vaccinated.
Beliefs about consequences
Participants tended to believe that pandemic influenza
was similar to seasonal influenza, which was not consid-
ered to be a serious illness. If participants thought that
the consequences of being ill with pandemic influenza
were minimal there was little incentive to take precau-
tionary measures.
A week being ill [with flu] isn’t the end of the world. I
think if I thought it was going to be much worse than
that, you know, I would be more concerned and more
likely to have the vaccine. (Female, underlying illness)
There was a view that the consequences of being vac-
cinated were potentially worse than becoming ill from
influenza. In many cases this was related to concerns
about side effects or a belief that it was possible to con-
tract influenza from the vaccine itself. These views were
not shaped by personal experience.
What I feel about vaccines is that you actually get a
virus or not – what you get is a small amount so you
are not supposed to get an illness. I am not sure that
is true. I have heard that many people do get ill after
having the vaccine… (Mother with young children)
Only a minority of participants were openly critical of
vaccine safety or efficacy but where such concerns were
expressed they were given as reasons not to be vacci-
nated. In expressing scepticism about the safety of a
newly developed vaccine the participants drew on beliefs
or representations of how drugs are developed and made
available to the public, and argued that a pandemic flu
vaccine cannot meet the standard safety criteria due to
its ‘sudden’ production:
Every other drug has been tested for years and years
before it can go on the shelf. How can they suddenly
produce something in six months and put it on the
shelf? I’d be very suspicious of that. (male, not at-risk)
By contrast, a facilitator of vaccine uptake was the
belief that a vaccine would be protective. This was of
particular relevance to those who were aware that they
could have complications as a result of becoming ill, for
example, pregnant women who were concerned to pro-
tect their babies: ‘It’s only because I’m pregnant that I’m
more worried, because otherwise I wouldn’t [be]’.
A further facilitator of vaccine uptake was anticipated
regret: a tendency to consider that the situation could
become worse and that there could be negative conse-
quences from not being vaccinated early enough. As this
young man who was not at-risk said: ‘It would be a
brave man to say no, I’m not taking anything at all when
everyone around you is dropping’.
Social identity
Those who were accepting of vaccination and antiviral
medicines tended to view themselves as less healthy and
acknowledged that they could be at risk of infection
from pandemic influenza. They were frequently in con-
tact with medical professionals and followed their advice
and routinely took medication and the seasonal influ-
enza vaccination. Many were from a seasonal influenza
priority group and regarded the decision to get vacci-
nated or take medicines as ‘normal’:
I think if you are already in a group such as us, who
are already taking loads of medications, constant
checks and tests, you tend to be a bit more accepting.
Whereas if you don’t take medications, you’re
normally quite healthy and you are suddenly being
told ‘we want you to have this, we recommend you
take it’. (Female, underlying illness)
Pregnant women considered themselves to be tempor-
arily in the at-risk category, although most commented
that they would prefer not to take medicines in case of
harm to the foetus but would do so if a medical profes-
sional recommended it.
By comparison, those participants who were less accept-
ing of vaccination advice tended to perceive themselves as
‘fit and healthy’ and have had less frequent contact with
medical professionals. Notions of being ‘fit and healthy’,
rarely becoming ill and having a strong immune system
were invoked to deny the need for vaccination because
they were unlikely to be at–risk. A range of behaviours
such as, eating healthily and exercising were believed to
confer this immunity.
…look after yourself, eat healthier and do a bit of
exercise and try and keep away from people with
viruses and that sort of thing and um I do that
without sort of getting neurotic about it. (Male,
underlying illness)
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way to stave off infection: social distancing, lifestyle re-
lated activities, and improving basic hygiene. More than
half of participants spontaneously mentioned distancing
behaviours as a means to reduce the risk of being in-
fected, e.g. avoiding crowds, not travelling on public
transport, and staying at home:
I think people will stay indoors, and people will not
congregate - meetings or anything like that, supermarkets,
trains… (Male, not at risk)
About one third cited lifestyle behaviours as a means
of staving off infection such as eating properly, drinking
more water, exercising and supplementing their diet with
vitamin C, cod liver oil or orange juice. Finally, improved
hygiene behaviour was often mentioned such as using
hand gels, washing hands more frequently, cleaning sur-
faces and covering one’s face when sneezing or coughing.
Using alternative behaviours to vaccination related to
the view that medicine should be avoided where possible
and that it was better to allow the body to fight off dis-
eases ‘naturally’. Arguably, some people preferred these
precautionary behaviours to vaccination because they
seemed without side-effects and also more within their
direct control. People who held these views could be
from either an at-risk or not-at-risk group:
I would be very happy for my own body to make an
attempt to try and fight it because what I know about
vaccines is that they break the immune system.
(Female, mother with young children)
I’m not a great fan of taking medicine for medicines
sake really. I think that’s probably the criteria that I
applied and I’m just reluctant I think to take
something which at the end of the day um I don’t
really see the benefit of really. (Male, not at-risk)
Beliefs about being fit and healthy and being able to
naturally fight disease contributed to a sense of optimism:
the belief that that they were less vulnerable than others
to being infected with pandemic influenza:
…touch wood, I feel I’m quite healthy anyway…I seem
to be alright. (Pregnant woman)
I’m alright, I’ll do the best I can, I’ll do my exercise
which is my overall shield, my barrier against all
diseases… (Male, underlying illness)
Social role
Pregnant women were aware of their social role to pro-
tect their unborn child but others also commented that
their social role as a protector of their family or as a role
model to family members would influence them in the
direction of being vaccinated:
If you are a family person and you have got children
that are under sixteen, for example, it’s up to you to
decide whether they would have this vaccination, and
if you say no, I’m not going to let them have it and they
die, that’s a big responsibility on you. (Male, not at-risk)
…this is a collective thing (Female, not at-risk)
…it’s not just about you is it, it’s about everyone else
(Pregnant woman)
H o w e v e r ,o n l yam i n o r i t yo fp a r t i c i p a n t sb e l i e v e dt h a t
they had a social responsibility to be vaccinated in order to
prevent the circulation of the virus within the wider society.
Virtually no participant referred to the notion of herd im-
munity and to the duty of every citizen to vaccinate to
reduce others’ risk of infection. Thus, it could be argued
that the risk of pandemic influenza was primarily under-
stood as a personal rather social issue, with little attention
being paid to the social aspects of a pandemic outbreak.
Opportunities
Physical opportunities
The main physical opportunity that appeared to promote
uptake of vaccination was access to advice and treat-
ment. Participants anticipated that vaccination would be
readily available at GP surgeries or at pharmacies. How-
ever, surgeries were considered to be a ‘hub for infection’
which should be avoided:
You are going into an environment where you are prone
to get flu because there is different people, so I’db e
scared. I think I’db el i k ec a n ’t you just post it through
the door, like send it, I don’tk n o w ,Iw o u l d n ’tg ot ot h e
centre. Would you? (Mother with young children)
The anxiety about attending a surgery prompted one
participant to suggest that mobile dispensaries should
come to local neighbourhoods ‘to bring the medication
to you’ (Male, not at-risk). In addition, there was concern
about the difficulty of booking an appointment in a timely
fashion because of pressures on the health service.
Social opportunities
Social influences included recommendations from trusted
sources, especially health professionals, taking account of
the behaviour of respected others, and the influence of the
media.
Participants believed that they would actively seek
advice from their GP in a pandemic situation and would
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‘I am not a medic and therefore I follow his advice’
(Male, not at-risk). However, in an uncertain scenario
some participants commented that they would seek
additional supporting evidence on the internet. Never-
theless, if a GP made a strong recommendation to
be vaccinated, most participants would follow their
advice:
If it is very, very strongly recommended [in uncertain
scenario], well then I would go and beat the surgery
door down and get a vaccine, but um if the advice
isn’t that strong well then I’d leave it for a bit and see
how I get on. (Male, underlying illness)
Participants were also likely to respond to sources of
informal advice, for example close friends and family, an
authority in the workplace or a local community leader.
This was particularly evident among a group of elderly
Somali women and a group of men in a close-knit area
of Central London who said that they would actively
seek the advice of community leaders.
Participants acknowledged that the media will play a
role during a pandemic outbreak and they expected that
they would get information ‘from reliable newspapers
not the Sun or Metro’ (Pregnant woman). A common ex-
pectation was that the media would exaggerate the situ-
ation because ‘you hear it on the news and you obviously
have to take it with a pinch of salt because the news
media are always out for a story’ (Male, not at-risk).
Group identity
Identifying as being part of a group was a factor in
decision-making about vaccination. This was because
several people with underlying conditions belonged to
support groups either in person or on-line. These groups
would sometimes discuss the need for vaccination
…the people in the online forum talk about flu
vaccination…. I know from reading online that it
covers people like me (Female, underlying illness)
However, despite being aware that one was part of an
at-risk group, some people who were in the at-risk
groups distanced themselves emotionally from the need
to be vaccinated. One female participant who had Pri-
mary Sclerosing Cholangitis
c argued that she would only
think of herself as being vulnerable if the people who
were infected were from the same country and demo-
graphic as herself:
I think does the risk of getting the vaccine outweigh the
risk of the impact on my life. I guess when it is a
million miles away and very few people are getting it
and it’s a different age demographic to me, I probably
think actually I am not going to take that risk [of
being vaccinated]….. (Female, underlying illness)
Additional factors that may influence uptake of antiviral
medicines
Beliefs about antiviral medicines tended to be ill-informed,
for example, considering that they were antibiotics and
that they would be delivered in injection form.
Many were unsure whether they would recognise the
signs of pandemic influenza, for example,‘What are
the symptoms? Are there different symptoms from
swine flu and ordinary flu? What would you look out
for? How would you know you had one from the
other?’ (Male, not at-risk)
Most of the participants commented that the advice to
take antiviral medicines seemed ‘sensible’ and compared
with vaccination fewer concerns were raised. Overall
there was less resistance to uptake because ‘if you were
feeling ill and feeling like death, you would take anything’
(Male, not at risk).
Discussion and conclusions
The aim of this study was to systematically identify
facilitators of and barriers to being vaccinated and take
antiviral medicines in uncertain and severe pandemic
influenza scenarios using the COM-B framework. The
influences on vaccination and antiviral uptake were
wide-ranging, including various aspects of capability,
motivation and social opportunity, with some evidence
that addressing one aspect could impact on others in
the system. For example, social opportunity in the
form of recommendations from respected others
influenced reflective motivations in the form of
beliefs about vaccine efficacy. This suggests that the
influences on vaccine and antiviral uptake are multi-
dimensional and that communications to promote
u p t a k ea r el i k e l yt ob em o s te f f e c t i v ei ft h e ya d d r e s s
several components.
Identity as a healthy or at-risk individual influenced
whether or not people thought they were vulnerable to
contracting pandemic influenza and whether they be-
lieved that practicing alternative protective behaviours
could be as effective as vaccination. Feelings of vulner-
ability were engendered by being labelled as being in a
clinically at-risk group (having an underlying illness,
being older or pregnant), and by the severity of the
scenario because if it was perceived to be very severe all
people will be susceptible to pandemic influenza.
In contrast, those who felt invulnerable to pandemic
influenza cited the rarity of being ill with flu and be-
lieved that they were, young, healthy or fit and hence
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structed an identity as ‘a healthy person’ were less will-
ing to follow advice to be vaccinated and did not view
using biomedicine as ‘normalised’. The use of alternative
behaviours, especially eating well, exercising and using
vitamin supplements was thought to boost immunity
and hence, reduce the risk of being infected and the
need for vaccination.
Beliefs about being able to boost one’s natural immun-
ity were held by those who were clinically at-risk, as
well as by those who were not at-risk. This study
s u g g e s t st h a tm a n yp e o p l ei np r i o r i t yg r o u p sd on o t
self-identify as being vulnerable and may, therefore, not
make the connection with messages aimed at them.
Such a disconnection could explain why only 37.65% of
those in priority groups in the UK were vaccinated dur-
ing the last pandemic [5]. More may need to be done to
ensure that those in a priority group are able to identify
themselves as being more susceptible to the effects of
pandemic influenza than others.
Promoters of and barriers to uptake cannot be consid-
ered separately from the context of the scenario: in a
high risk scenario intentions to follow advice to be vacci-
nated or to take antiviral medicines were high whereas
in the uncertain scenario there was hesitancy and am-
bivalence and it was in this situation that the full range
of doubts, concerns and misperceptions emerged.
COM-B as a framework for analysis was a useful
starting point for identifying the range of factors
associated with uptake of vaccination and antiviral
medicines. The barriers and facilitators of uptake could
be classified within the framework which allowed an
explanation of behaviour across several components.
Many of the factors discussed have been identified in
previous studies; for example this study supports previ-
ous research that one of the most consistent predictors
of vaccine uptake is the habit of being vaccinated for
seasonal influenza [8-10,14,19], that the role of emo-
tion (automatic motivations) is highly relevant [11] and
that a barrier to vaccine uptake is negative beliefs about
the vaccine such that the consequences of being vacci-
nated are perceived to be as or more problematic than
the consequences of becoming ill with pandemic influ-
enza [18,19,21,33,44,45].
However, comparison between studies is made difficult
because different researchers select a small sub-set of
predictor variables to examine; only a minority make use
of a model of behaviour to explain why these variables
were selected (exceptions are Teasdale & Yardley 2011 [27],
Myers & Goodwin 2012 [46], and Kok et al 2010 [12])
or accommodate different levels of severity.
COM-B is a theoretical starting point for understand-
ing behaviour within specific contexts and to make a
‘behavioural diagnosis’ o fw h a tn e e d st oc h a n g et oa l t e r
behaviour. It is at the centre of the Behaviour Change
Wheel [40] - a tool to guide intervention design by
identifying which intervention functions are likely to be
most effective. It is beyond the scope of this paper to
enumerate the range of potential interventions but a
few examples are described below:
 The study indicated that identity as a ‘healthy person’
was a barrier to being vaccinated. Messages that
address these beliefs – for example, explaining how
no-one is immune to a new strain of flu and that being
vaccinated can enhance health by boosting immunity
– may be effective in increasing uptake.
 A further barrier to uptake was a belief that lifestyle
behaviours such as eating healthily and exercising
could confer immunity and make people less
vulnerable to contracting pandemic influenza.
Communications that address these beliefs might
include information about why people are
vulnerable to a new strain of influenza and about
the effectiveness of vaccines in reducing the risk of
infection or in boosting immunity.
Although the participants were purposively sampled to
represent a range of risk profiles, a limitation of this
research was that the sample may not reflect the views
of the wider population because it was not represen-
tative and focus groups may attract people who are
particularly interested in the topic area. Furthermore, it
is not clear whether being in the habit of being vacci-
nated or not being vaccinated conditioned responses to
different scenarios. This could be explored in future
research.
Future research needs to take account of the extent to
which messages about vaccination can be transparent in
addressing concerns about the vaccine; for example
being more open about how the vaccine is developed. In
addition, we should investigate whether messages that
address identity are effective in promoting uptake of
vaccination. In particular, to examine whether positively
framed health messages that focus on wellbeing are
more effective than messages about risk reduction for
individuals who do not self-identify as being vulnerable
to infection.
The promoters and barriers to being vaccinated and
taking antiviral medicines are multi-dimensional, and
communications to promote uptake are likely to be
most effective if they address several components of be-
haviour. The benefit of using the COM-B model is that
it is at the core of an approach that can identify effective
strategies for behaviour change or communications for
the future. People from at-risk groups do not always
perceive themselves to be at-risk because they have
constructed an identity as a healthy person who is
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lifestyle. Communications should confront these identity
beliefs by addressing how vaccination can boost wellbeing
and immunity.
Endnotes
aThe original TDF was developed by an international
panel of 32 experts in behaviour change who identified
128 constructs from 33 behaviour change theories and
simplified them into domains. Usability was developed
with an international team of implementation scientists.
The TDF has been validated and refined by an inter-
national panel of 36 experts in behaviour change.
bParticipants are referred to by gender and whether
they are in an at-risk group (over 65 years, pregnant,
underlying illness) or not in an at-risk group (included
mothers with young children).
cPSC is a disease of the liver and people with this con-
dition are recommended to have the influenza vaccine
because they have lowered immunity as a result of the
treatments they receive.
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